Sabesp at 28.16: What the Split Mechanics Buried

The consensus average sits at 33.07 against a current 28.16, or roughly 17% headroom. More interesting is what happened on the way down. Almost half of the one-month drop from 33.40 to 28.16 was not a repricing of the business at all. The late-April 1-for-5 split mechanically reset the quote while expanding the share count, a liquidity adjustment with no bearing on earnings power that still prints on the chart as if something broke. Strip that out and what remains is a valuation-driven downgrade to Neutral on a BRL38 target, which still sits above the stock.

The discount holds up under inspection. Trailing operating margin is 33.15%, essentially flat against 2025’s 33.08%, on revenue of 39,630 million BRL that grew in the high single digits. For a regulated utility, that spread between revenue growth and margin stability is the whole game: tariff pass-through and the capex recovery cycle, not volume heroics, determine what reaches the equity line. Sabesp converted roughly 8,730 million BRL of that revenue into net income, and the operating line held its share even as top-line growth decelerated. To me, that says the cost discipline management pushed through the post-privatization period is being recovered in the tariff schedule rather than leaking away.

The first-quarter print sharpened that read. Adjusted net revenue rose 11% year over year and adjusted net income climbed 32%, with EPS well ahead of sell-side estimates, and the stock managed only a modest premarket bounce before the post-split tape swallowed it. That is the disconnect that matters: operations accelerated in the same window the price fell, so the move was flow and mechanics, not deterioration in the recovery cycle.

I trust that durability because of the regulatory plumbing. Sabesp is implementing the RAB methodology, the Regulatory Asset Base framework that governs how invested capital earns a return, with completion targeted for year-end 2026, while ARSESP runs a public consultation on the related DRC methodology that shapes tariff reviews and asset integration. The 2020 federal sanitation framework, Law 14.026, continues to standardize regulation nationally and push private participation toward roughly half the sector by the end of 2026. That matters because it reduces the political interference in tariffs that historically made Brazilian sanitation a value trap. A regulated revenue base whose pass-through cadence is being formalized rather than negotiated case by case is exactly the setup where a capex recovery cycle compounds into the rate base instead of getting clawed back at the next review. The mechanism is similar to other Brazilian asset-heavy names where the argument lives or dies on recovery math rather than sentiment, as in this margin-math frame.

Against that backdrop, the capital plan reads as setup rather than strain. Capex roughly doubled in 2025 to 15.2 billion BRL, aimed at universalization targets through 2033, and the EMAE stake and the Cade-cleared Sanessol acquisition extend the asset footprint the new methodology should eventually let the company recover on. The right lens here is EV against a growing rate base and a P/E on regulated EPS, not dividend yield as a bond proxy, because the equity story over the next several years is the conversion of that capex into recoverable, return-earning assets. The market is discounting spending it should, under the formalizing framework, be paid back for.

That does not erase the places where the thesis can crack. The DRC consultation closing in May 2026 could land with a recovery cadence slower than the capex deployment assumes, meaning the 15.2 billion BRL flows out faster than the tariff schedule lets it return and compresses the margin stability the bull case rests on. Then there is the debt stack: 51,640 million BRL gross, 32,460 million net, and any foreign-denominated tranche gets more expensive to service as the real depreciates, a drag beneath the operating margin that does not show up in the 33% figure. Insider selling by a senior executive in late May is the kind of signal I note without overweighting, but it sits beside a downgrade explicitly about valuation, and valuation downgrades on a stock trading below the downgrader’s own target tend to age awkwardly.

The cleanest way to hold myself accountable is the margin itself, because it is the variable the regulatory transition either protects or erodes. If trailing operating margin falls below 30% for two consecutive quarters, the read that tariff pass-through is recovering the capex cycle is wrong, and the discount to 33.07 stops being a mechanical artifact and becomes the market pricing a real squeeze. Until that happens, the gap between where Q1 operations went and where the post-split quote landed is the opportunity. This one is arithmetic, not narrative.

Figures reflect the most recent available data and may differ slightly from live market prices. · © Mathstock